The consortium is competing against EQT. Mumbai-based pharma co likely to be valued at $1.8 bn. Binding bids are scheduled for next week.

Inside one of India’s earliest assessment-driven awards programmes honouring excellence across manufacturing, digital transformation, and s...

Quadria Capital is exploring options to sell its stake in Encube Ethicals. The healthcare investor considers both a controlling stake sale ...

Quadria Capital is set to acquire a 10% stake in Aragen Life Sciences for about $100 million, valuing the Indian CRDMO at $1.2 billion. The...

Indian pharmaceutical companies are becoming more aggressive and increasing their market share and capex. Companies such as Divis, Dr Reddy...

The project is part of the Lodha Lifesciences Hub, which is spread across 25 acres and is Mumbai’s first systematically developed life scie...

The year 2021 has seen the highest-ever IPO volumes in the country with the volumes surging to USD 15.3 billion, as against USD 4.2 billion...

Encube Ethicals has agreed to buy popular topical anti-microbial brand Soframycin and other brands from French drugmaker Sanofi for India a...

We take a closer look into how the United States and India view and treat Big Tech companies.

In today's ETtech Morning Dispatch: Acko raises $200 million to become India's latest startup unicorn, Govt-Twitter spat set up escalate ov...

Quadria Capital, which has backed Nobel Hygiene and Encube Ethicals within the last one week, plans to deploy $400-500 million in India ove...

Encube Ethicals’ funding round, that saw participation of Quadria Capital and Gulf Islamic Investments, provides an exit to early backer Re...

Encube Ethicals' promoter Mehul Shah will also sell about 5-10% stake in the company. A clutch of private equity funds, including Carlyle, ...

"The launch of product is an important addition to our pain/analgesics portfolio of over-the-counter (OTC) products, and represents our con...